SWOT Analysis for Lyra Therapeutics Inc

Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)

Companies with High Debt
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Biggest Price Losers from Open
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Companies Increasing Debt as per Annual Report
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter